Six‐Weekly Versus Monthly Haemodialysis Blood Testing in an Australian Tertiary Kidney Service: A Quality, Safety, Green Nephrology Initiative and Cost‐Saving Analysis
Nephrology · 2026-04 · 31 (4)
DOI: 10.1111/nep.70202 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Nephrology, online erschienen am 01.04.2026. Verfasst von Daniel Hirsch und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Renal Medicine, Wollongong Hospital, Wollongong, New South Wales, Australia. Hauptthemen laut MEDLINE: Renal Dialysis, Hematologic Tests. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
There is limited evidence to guide optimal frequency of surveillance bloodwork for haemodialysis patients. In September 2023, surveillance bloodwork frequency was reduced from monthly to 6‐weekly across 4 Illawarra‐Shoalhaven dialysis units. We retrospectively evaluated actual frequency of blood tests, safety (all‐cause hospitalisations, hospitalisations for hyperkalaemia, percentage of potassium and haemoglobin levels in target ranges), cost‐savings and environmental impact (reduction in carbon emissions and waste generation) of 6‐weekly versus monthly scheduled bloodwork for clinically stable patients receiving in‐facility haemodialysis during the 12‐months before and after this practice change. Staff perspectives were gathered via survey. We analysed 99 patients with monthly surveillance bloodwork and 101 patients with 6‐weekly bloodwork. After reducing to 6‐weekly scheduled bloodwork, frequency of FBC/EUC/CMP blood tests decreased from 48.3 to 34.9 per patient‐year. Comparing 6‐weekly versus monthly groups, there was no increase in percentage of patients with ≥ 1 hospitalisation (72% vs. 73.5%, p = 0.70), hospitalisation for hyperkalaemia (0.8% vs. 0.9%, p = 0.92); percentage of patients with potassium levels (3.5–5.9 mmol/L) was similar (86.0% vs. 86.2%, p = 0.88). Proportion of haemoglobin levels in target range (100–115 g/L) decreased from 45.4% to 38.5% ( p < 0.01) but with no clear changes in Erythropoietin Stimulating Agent use. Overall, there were 3.8 fewer blood draws, 8.7 fewer blood tubes used, $AUD201.44 saved in pathology costs and carbon emissions reduced by 1.03 kg per patient‐year. Of 58 dialysis nurses, 47 (81%) responded to a survey and indicated the practice change was acceptable (38/47, 81%). Reducing surveillance bloodwork frequency to 6‐weekly for haemodialysis patients delivered substantial cost‐savings and had positive environmental benefits without compromising safety. Strong engagement with dialysis staff supports its scalability and sustainability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Renal Medicine, Wollongong Hospital, Wollongong, New South Wales, Australia.
- Faculty of Medicine & Health, University of New South Wales Sydney, Sydney, New South Wales, Australia.
- Graduate School of Medicine, University of Wollongong, Wollongong, New South Wales, Australia.
- School of Medical, Indigenous and Health Sciences, University of Wollongong, Wollongong, New South Wales, Australia.
- Kidney Lifestyle Research Group, University of Wollongong, Wollongong, New South Wales, Australia.
- Renal and Metabolic Division, The George Institute for Global Health, UNSW Medicine & Health, Sydney, New South Wales, Australia.
ORCID-Profile: Daniel Hirsch, Kelly Lambert, Karumathil Murali, Wing-Chi Gigi Yeung, Jeffrey T Ha
Zitieren
APA
Hirsch, D., George, D., Pugh, D., Kwiatkowski, M., Staker, S., Watson, J., Chen, J. H. C., Lambert, K., Murali, K., Yeung, W. G., & Ha, J. T. (2026). Six‐Weekly Versus Monthly Haemodialysis Blood Testing in an Australian Tertiary Kidney Service: A Quality, Safety, Green Nephrology Initiative and Cost‐Saving Analysis. Nephrology, 31(4). https://doi.org/10.1111/nep.70202
Vancouver
Hirsch D, George D, Pugh D, Kwiatkowski M, Staker S, Watson J, et al. Six‐Weekly Versus Monthly Haemodialysis Blood Testing in an Australian Tertiary Kidney Service: A Quality, Safety, Green Nephrology Initiative and Cost‐Saving Analysis. Nephrology. 2026;31(4). doi:10.1111/nep.70202
BibTeX
@article{Hirsch2026,
author = {Hirsch, Daniel and George, Donia and Pugh, Debbie and Kwiatkowski, Monica and Staker, Samantha and Watson, Jake and Chen, Jenny H C and Lambert, Kelly and Murali, Karumathil and Yeung, Wing-Chi Gigi and Ha, Jeffrey T},
title = {Six‐Weekly Versus Monthly Haemodialysis Blood Testing in an Australian Tertiary Kidney Service: A Quality, Safety, Green Nephrology Initiative and Cost‐Saving Analysis},
journal = {Nephrology},
year = {2026},
volume = {31},
number = {4},
doi = {10.1111/nep.70202}
}
EUVIMED